Category: Ultrasound

Misonix's Q2 sales fall as it swings to red ink

February 16, 2010 by MassDevice staff

Misonix Inc. (NSDQ: MSON) posted second-quarter sales of $3.4 million for the three months ended Dec. 31, 2009, down 31 percent compared with $4.9 million during the same period in fiscal 2009. Net losses were $367,000, compared with net income of $194,000 during Q2 2009:

GE Healthcare launches handheld ultrasound device

February 15, 2010 by MassDevice staff

GE Healthcare's handheld ultrasound device, the Vscan, hit the market in the U.S., Europe, India and Canada today.

The device, which is roughly the size of a smart phone, won 510(k) clearance from the Food & Drug Administration, CE Mark approval in the European Union and a Medical Device License from Health Canada. GE ran a study of the device's use in real-world setting before a wider release.

SonoSite's Q4 net plunges on flat sales

February 12, 2010 by MassDevice staff

SonoSite Inc. (NSDQ:SONO) posted fourth-quarter sales of $69.7 million for the three months ended Dec. 31, 2009, flat compared with $70.1 million during the same period in 2008. Net income fell 63.4 percent to $2.2 million, compared with $6 million during Q4 2008:

UPDATE: Covidien sues J&J unit Ethicon over ultrasound devices

January 15, 2010 by MassDevice staff

Tyco Healthcare v. Ethicon Endo-Surgery is becoming a grudge match for the ages.

Two years after a federal court judge essentially declared their long-running patent fight a tie -- siding with Ethicon by dismissing the case but also telling Tyco it was free to re-file -- Covidien plc, Tyco Healthcare's successor company, is now doing exactly that.

Misonix extends reach in South America

January 12, 2010 by MassDevice staff

Misonix Inc. (NASQ:MSON) struck a deal to sell its SonaStar and BoneScalpel surgical tools in Chile.

Officials with Farmingdale, N.Y.-based Misonix said the new distribution agreement with Neuromed Chile SA coincides with a renewed focus by the ultrasound device manufacturer on the Latin American market.

"We are particularly pleased that they will be distributing two of our key products through their well established surgical products organization," Misonix Chief Executive Michael McManus said in prepared remarks.

Misonix swings into the red during Q1

November 17, 2009 by MassDevice staff

Misonix Inc. (MSON) posted first-quarter sales of $2.7 million for the three months ended Sept. 30, down 12.6 percent compared with $3.1 million during the same period last year. The Farmingdale, N.Y.-based ultrasound device maker swung into the red for Q1 2010, posting a net loss of $776,000 compared with net income of $320,000 during Q1 2009:

Press Release

Misonix Reports First Quarter Fiscal 2010 Financial Results